Abstract. Matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and membrane-type matrix metalloproteinase 1 (MT1-MMP) are involved in colorectal cancer invasion and metastasis. Reversion-inducing cysteinerich protein with Kazal motifs (RECK) inhibits MMP-2, MMP-9 and MT1-MMP. We examined the clinicopathological significance of the relative expression of these genes in patients with colorectal cancer, especially with regard to metastasis. We studied surgical specimens of cancer tissue and adjacent normal mucosa obtained from 205 patients with untreated colorectal carcinoma. MMP-2, MMP-9, MT1-MMP, RECK and ß-actin mRNA of cancer tissue and adjacent normal mucosa were measured by quantitative real-time reverse-transcriptase polymerase chain reaction. MT1-MMP gene expression was higher in cancer tissue than in adjacent normal mucosa. In contrast, MMP-2, MMP-9 and RECK gene expression levels were lower in cancer tissue than in adjacent normal mucosa. As for the relationship between the gene expression and clinicopathological factors, MMP-2 expression correlated with the depth of invasion, venous invasion and liver metastasis; MMP-9 and RECK expression correlated with venous invasion. There were positive correlations among the gene expression levels of MMP-2, MMP-9 and RECK. MMP-2 gene expression was considered a useful predictor of liver metastasis from colorectal cancer.
Introduction
Colorectal cancer, one of the most prevalent cancers worldwide (1) , is the second leading cause of cancer-related mortality in developed countries (2) . Tumor cell invasion and metastasis involve multiple steps, including proteolytic degradation of the basement membrane (BM) and extracellular matrix (ECM), altered cell adhesion and the physical movement of tumor cells. Among the many steps of tumor invasion and metastasis, excessive degradation of the matrix is one of the hallmarks of this process (3) .
Matrix metalloproteinases (MMPs) are a key family of proteolytic enzymes involved in extracellular matrix degradation. In colorectal cancer, several MMPs have been found to be associated with tumor stage, prognosis, or both (4). Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) have been implicated in the progression, invasion and metastasis of colorectal cancer in animal models and patients (5) . MMP-2 and MMP-9 can degrade denatured collagen and type IV, V, VII, IX and X collagens. Type IV collagen is particularly abundant in basement membranes. These gelatinases are now also thought to be involved in cell differentiation, apoptosis, angiogenesis, immune response and cancer cell growth (6) . The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene was originally ONCOLOGY REPORTS 19: 1285 -1291 , 2008 (9) . Although RECK is widely expressed in normal tissues and non-neoplastic cell lines, its expression is strongly suppressed in oncogene-transformed fibroblasts and several tumor-derived cell lines (9, 10) . RECK inhibits MMP-2, MMP-9 and membrane-type matrix metalloproteinase 1 (MT1-MMP) secretion and activity, suggesting that it participates in the regulation of MMPs and tumor invasiveness (11) . RECK is also vital to developmental vasculogenesis and its down-regulation has been implicated in tumor angiogenesis and progression (9, 11, 12) . In this study, we examined the clinicopathlogical significance of the relative expression of these genes in patients with colorectal cancer, especially with regard to metastasis. Quantitative real-time reverse-transcriptase polymerase chain reaction (PCR). Total RNA from colorectal cancer tissue and adjacent normal mucosa was prepared with the use of Trizol (Gibco, Life Tech, Gaithersburg, MD). cDNA was synthesized from 2 μg of total RNA using an iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). After synthesis, the cDNA was diluted 1:4 with water and stored at -20˚C until use. Quantitative real-time PCR was performed with iQ SYBR-Green Supermix (Bio-Rad Laboratories). PCR reactions were carried out in a total volume of 15 μl, containing cDNA derived from 75 ng of RNA, 0.27 μM of each primer, 7.5 μl of iQ SYBR-Green Supermix containing dATP, dCTP, dGTP and dTTP at a concentration of 400 μM each and 50 U/ml of iTag DNA polymerase. The PCR consisted of 10 min at 94˚C followed by 50 cycles of denaturation of the cDNA for 30 sec at 94˚C, annealing for 30 sec at an appropriate temperature according to Table I and a primer extension for 1 min at 72˚C, followed by 72˚C for 10 min. The PCR primer sequences of MMP-2, MMP-9, MT1-MMP, RECK and ß-actin, used as an internal control are shown in Table I .
Materials and methods

Patients
Statistical analysis. Associations of the gene expression levels of colorectal cancer with those of adjacent normal mucosa were evaluated by the Wilcoxon test. The relationship between the gene expression levels and potential explanatory variables, including age, gender, tumor size, histological type, depth of invasion, lymph node metastasis, location, lymphatic invasion, venous invasion and liver metastasis, were assessed with the χ 2 test. Associations among variables were evaluated with the Mann-Whitney U test. Correlation coefficients between different variables were determined by a simple regression analysis. Statistical analyses were performed using Statview J 5.0 software (Abacus, CA). Two-sided P-values were calculated and P-values <0.05 were considered to indicate statistical significance.
Results
Comparison of MMP-2, MMP-9, MT1-MMP and RECK mRNA expression between colorectal cancer tissue and adjacent normal mucosa. MMP-2, MMP-9
and RECK gene expression levels were lower in cancer tissue than in adjacent normal mucosa (P=0.004, 0.001 and 0.006; Fig. 1A, B and D) . In contrast, MT1-MMP gene expression in cancer tissue was higher than that in adjacent normal mucosa (P=0.038; Fig. 1C ).
Relationship between clinicopathological features to MMP-2, MMP-9, MT1-MMP and RECK gene expression levels. After Table I . PCR primers and conditions. Table II. The relationship between the expression of MMP-2, MMP-9, MT-MMP or RECK genes and clinicopathological features.
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related to the depth of invasion (P=0.018). MMP-2, MMP-9, and RECK gene expression levels were significantly related to venous invasion (P=0.011, 0.025 and 0.035). MMP-2 expression was also significantly related to liver metastasis (P=0.032) ( Table II) .
Comparison of MMP-2, MMP-9, MT1-MMP and RECK gene expression levels according to the presence and absence of lymph node metastasis. There were no significant differences in MMP-2, MMP-9, MT1-MMP and RECK gene expression levels according to the presence or absence of lymph node metastasis (Fig. 2) .
Comparison of MMP-2, MMP-9, MT1-MMP and RECK gene expression levels according to the presence or absence of venous invasion. MMP-2, MMP-9
and RECK gene expression levels differ significantly according to the presence or absence of venous invasion (P=0.0462, 0.0488 and 0.0491) (Fig. 3) .
Correlation among MMP-2, MMP-9 and RECK expression.
The results of a correlation analysis are shown in Fig. 4 . Correlations were observed between the gene expression levels of MMP-2 and MMP-9 (R=0.739), MMP-2 and RECK (R=0.761) and MMP-9 and RECK (R=0.606) (Fig. 4) .
Discussion
MMP-2 and MMP-9 play key roles in the development and progression of human malignancies (13) (14) (15) . These matrix metalloproteinases mediate the destruction of extracellular matrix and are considered an important early step in tumor invasion and metastasis. MMP-2 and MMP-9 also have angiogenic activity and participate in early tumorigenesis and tumor growth, including metastasis (16, 17) . The overexpression of MT1-MMP in tumor cells promotes growth (18) . The RECK gene is believed to regulate multiple MMP family members, such as MMP-2, MMP-9 and MT1-MMP (12) . Several previous studies have compared MMP-2, MMP-9, MT1-MMP and RECK mRNA expression levels between colorectal cancer tissue and adjacent normal mucosa. Kim et al (19) reported that MMP-2 and MMP-9 gene expression levels (n=24) are higher in colorectal cancer than in adjacent normal mucosa. Lubbe et al (20) found that the MMP-9 gene expression level in colorectal cancer (n=28) is higher than that in adjacent normal mucosa. However, in our study (n=205), MMP-2, MMP-9 gene expression levels were higher in adjacent normal mucosa than in cancer tissue. We believe that this result was related to the higher expression of MMP-2 and MMP-9 in interstitial tissues than in cancer cells. Atkinson et al (21) showed that the MT1-MMP gene expression level is higher in cancer tissue than in adjacent normal mucosa, while Takeuchi et al (22) reported that the RECK gene expression level is higher in adjacent normal mucosa than in colorectal cancer. In our study, RECK gene expression levels were higher in adjacent normal mucosa than in cancer tissue. Conversely, the MT1-MMP gene expression level was higher in cancer tissue than in adjacent normal mucosa.
Zheng et al (23) studied the relationship between the clinicopathological features and gene expression levels of MMPs. The expression levels of MMP-2 and MMP-9 were found to be closely linked to venous and lymph node invasion. Ogata et al (24) reported that MMP-9 expression is related to lymph node metastasis and severe venous invasion. Takeuchi et al (22) reported that RECK expression is significantly associated with lymph node metastasis, Dukes' stage and venous invasion. In our study, MMP-2, MMP-9 and RECK expression levels were significantly related to venous invasion. MMP-2 expression was also significantly related to tumor depth and liver metastasis. MT1-MMP has been reported to specifically activate MMP-2 (25) . The association of MMP-2 expression with tumor depth, venous invasion and liver metastasis may be related to the finding that the MT1-MMP gene expression level was higher in cancer tissue than in adjacent normal mucosa in our study.
In a study examining interrelations among RECK, MMP-2, and MMP-9, van der Jagt et al found that RECK expression levels strongly correlate with the inhibition of MMP-2 enzyme activity, though not with the inhibition of MMP-9 activity (26). Masui et al reported a significant negative correlation between RECK activation and MMP-2 activation (27) . In our study, correlations were observed between gene expression levels of RECK and MMP-2, RECK and MMP-9 and MMP-2 and MMP-9. These results demonstrated a positive correlation between the expression of RECK and MMP-2 at the mRNA level, although RECK inhibited MMP-2 activity at the enzyme level.
In conclusion, our study showed that MMP-2, MMP-9 and RECK gene expression levels were higher in adjacent normal mucosa than in cancer tissue and correlated with each other. Expression levels of these genes were significantly related to venous invasion. MMP-2 gene expression is considered a useful predictor of liver metastasis from colorectal cancer.
